UniProt ID | AP4AT_HUMAN | |
---|---|---|
UniProt AC | Q96N21 | |
Protein Name | AP-4 complex accessory subunit Tepsin {ECO:0000305} | |
Gene Name | TEPSIN {ECO:0000303|PubMed:22472443, ECO:0000312|HGNC:HGNC:26458} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 525 | |
Subcellular Localization |
Golgi apparatus, trans-Golgi network membrane Peripheral membrane protein . Cytoplasmic vesicle . Cytoplasm, cytosol . Extensively colocalizes with AP-4 which mediates the recruitment of TEPSIN to the trans-Golgi network. |
|
Protein Description | Associates with the adapter-like complex 4 (AP-4) and may therefore play a role in vesicular trafficking of proteins at the trans-Golgi network.. | |
Protein Sequence | MAAAPPLRDRLSFLHRLPILLKGTSDDDVPCPGYLFEEIAKISHESPGSSQCLLEYLLSRLHSSSGHGKLKVLKILLYLCSHGSSFFLLILKRNSAFIQEAAAFAGPPDPLHGNSLYQKVRAAAQDLGSTLFSDTVLPLAPSQPLGTPPATGMGSQARPHSTLQGFGYSKEHGRTAVRHQPGQAGGGWDELDSGPSSQNSSQNSDLSRVSDSGSHSGSDSHSGASREPGDLAERVEVVALSDCQQELSLVRTVTRGPRAFLSREEAQHFIKACGLLNCEAVLQLLTCHLRGTSECTQLRALCAIASLGSSDLLPQEHILLRTRPWLQELSMGSPGPVTNKATKILRHFEASCGQLSPARGTSAEPGPTAALPGPSDLLTDAVPLPGSQVFLQPLSSTPVSSRSPAPSSGMPSSPVPTPPPDASPIPAPGDPSEAEARLAESRRWRPERIPGGTDSPKRGPSSCAWSRDSLFAGMELVACPRLVGAGAAAGESCPDAPRAPQTSSQRTAAKEPPGSEPSAFAFLNA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | PPLRDRLSFLHRLPI CCHHHHHHHHHHHCC | 27.02 | 20873877 | |
22 | Ubiquitination | HRLPILLKGTSDDDV HHHCCCCCCCCCCCC | 57.61 | 29967540 | |
23 (in isoform 2) | Phosphorylation | - | 30.35 | 28450419 | |
25 (in isoform 2) | Phosphorylation | - | 47.94 | 28450419 | |
32 (in isoform 2) | Phosphorylation | - | 28.52 | 20068231 | |
33 (in isoform 2) | Phosphorylation | - | 38.19 | 20068231 | |
43 (in isoform 2) | Phosphorylation | - | 22.09 | 22210691 | |
51 (in isoform 2) | Phosphorylation | - | 24.47 | 25159151 | |
53 (in isoform 2) | Phosphorylation | - | 2.93 | 28450419 | |
54 (in isoform 2) | Phosphorylation | - | 5.52 | 28450419 | |
170 | Ubiquitination | LQGFGYSKEHGRTAV CCCCCCCCCCCCCEE | 45.29 | - | |
201 | Phosphorylation | GPSSQNSSQNSDLSR CCCCCCCCCCCCCCC | 40.71 | - | |
248 | Phosphorylation | SDCQQELSLVRTVTR HHHHHHHHHHHHHCC | 24.86 | 24719451 | |
252 | Phosphorylation | QELSLVRTVTRGPRA HHHHHHHHHCCCCCC | 20.81 | 27174698 | |
254 | Phosphorylation | LSLVRTVTRGPRAFL HHHHHHHCCCCCCCC | 29.33 | 27174698 | |
262 | Phosphorylation | RGPRAFLSREEAQHF CCCCCCCCHHHHHHH | 31.06 | - | |
322 | Phosphorylation | QEHILLRTRPWLQEL HHHHHHHCCHHHHHH | 40.84 | 23403867 | |
330 | Phosphorylation | RPWLQELSMGSPGPV CHHHHHHHCCCCCCC | 21.98 | 23927012 | |
333 | Phosphorylation | LQELSMGSPGPVTNK HHHHHCCCCCCCCHH | 20.31 | 23401153 | |
338 | Phosphorylation | MGSPGPVTNKATKIL CCCCCCCCHHHHHHH | 33.85 | 23927012 | |
340 | Acetylation | SPGPVTNKATKILRH CCCCCCHHHHHHHHH | 48.33 | 25953088 | |
340 | Malonylation | SPGPVTNKATKILRH CCCCCCHHHHHHHHH | 48.33 | 26320211 | |
351 | Phosphorylation | ILRHFEASCGQLSPA HHHHHHHHCCCCCCC | 16.16 | 23403867 | |
356 | Phosphorylation | EASCGQLSPARGTSA HHHCCCCCCCCCCCC | 14.50 | 22167270 | |
395 | Phosphorylation | QVFLQPLSSTPVSSR EEEEEECCCCCCCCC | 38.56 | 28348404 | |
396 | Phosphorylation | VFLQPLSSTPVSSRS EEEEECCCCCCCCCC | 44.40 | 28348404 | |
397 | Phosphorylation | FLQPLSSTPVSSRSP EEEECCCCCCCCCCC | 25.08 | 28348404 | |
400 | Phosphorylation | PLSSTPVSSRSPAPS ECCCCCCCCCCCCCC | 22.65 | 22210691 | |
401 | Phosphorylation | LSSTPVSSRSPAPSS CCCCCCCCCCCCCCC | 36.69 | 32645325 | |
403 | Phosphorylation | STPVSSRSPAPSSGM CCCCCCCCCCCCCCC | 27.62 | 29978859 | |
407 | Phosphorylation | SSRSPAPSSGMPSSP CCCCCCCCCCCCCCC | 41.45 | 29978859 | |
408 | Phosphorylation | SRSPAPSSGMPSSPV CCCCCCCCCCCCCCC | 37.74 | 29978859 | |
412 | Phosphorylation | APSSGMPSSPVPTPP CCCCCCCCCCCCCCC | 38.08 | 28348404 | |
413 | Phosphorylation | PSSGMPSSPVPTPPP CCCCCCCCCCCCCCC | 24.85 | 28985074 | |
417 | Phosphorylation | MPSSPVPTPPPDASP CCCCCCCCCCCCCCC | 48.97 | 24719451 | |
423 | Phosphorylation | PTPPPDASPIPAPGD CCCCCCCCCCCCCCC | 30.64 | 29978859 | |
453 | Phosphorylation | PERIPGGTDSPKRGP CCCCCCCCCCCCCCC | 38.94 | 29255136 | |
455 | Phosphorylation | RIPGGTDSPKRGPSS CCCCCCCCCCCCCCC | 31.96 | 29255136 | |
457 | Ubiquitination | PGGTDSPKRGPSSCA CCCCCCCCCCCCCCC | 74.14 | 29967540 | |
492 | Phosphorylation | AGAAAGESCPDAPRA CCHHCCCCCCCCCCC | 29.99 | 28555341 | |
503 | Phosphorylation | APRAPQTSSQRTAAK CCCCCCCCCCCCCCC | 21.16 | 28555341 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AP4AT_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AP4AT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP4AT_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
HNRPC_HUMAN | HNRNPC | physical | 26496610 | |
GRP78_HUMAN | HSPA5 | physical | 26496610 | |
IMDH2_HUMAN | IMPDH2 | physical | 26496610 | |
TNPO1_HUMAN | TNPO1 | physical | 26496610 | |
LAMA2_HUMAN | LAMA2 | physical | 26496610 | |
RL10_HUMAN | RPL10 | physical | 26496610 | |
BACD2_HUMAN | TNFAIP1 | physical | 26496610 | |
RBM10_HUMAN | RBM10 | physical | 26496610 | |
BAP1_HUMAN | BAP1 | physical | 26496610 | |
M2OM_HUMAN | SLC25A11 | physical | 26496610 | |
AP4M1_HUMAN | AP4M1 | physical | 26496610 | |
SCAM3_HUMAN | SCAMP3 | physical | 26496610 | |
SF3A1_HUMAN | SF3A1 | physical | 26496610 | |
YMEL1_HUMAN | YME1L1 | physical | 26496610 | |
SF3B2_HUMAN | SF3B2 | physical | 26496610 | |
AP4S1_HUMAN | AP4S1 | physical | 26496610 | |
AP4E1_HUMAN | AP4E1 | physical | 26496610 | |
SF3B1_HUMAN | SF3B1 | physical | 26496610 | |
UNC50_HUMAN | UNC50 | physical | 26496610 | |
NARF_HUMAN | NARF | physical | 26496610 | |
RT18B_HUMAN | MRPS18B | physical | 26496610 | |
MED31_HUMAN | MED31 | physical | 26496610 | |
STK26_HUMAN | STK26 | physical | 26496610 | |
KI16B_HUMAN | KIF16B | physical | 26496610 | |
DERL1_HUMAN | DERL1 | physical | 26496610 | |
ISCA1_HUMAN | ISCA1 | physical | 26496610 | |
ASCC2_HUMAN | ASCC2 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333; SER-356 ANDSER-455, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 (ISOFORM 2),AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND MASSSPECTROMETRY. |